Geographic Distribution of Providers With a DEA Waiver to Prescribe Buprenorphine for the Treatment of Opioid Use Disorder: A 5-Year Update
- PMID: 29923637
- DOI: 10.1111/jrh.12307
Geographic Distribution of Providers With a DEA Waiver to Prescribe Buprenorphine for the Treatment of Opioid Use Disorder: A 5-Year Update
Abstract
Purpose: Opioid use disorder (OUD) is a substantial public health problem. Buprenorphine is an effective medication-assisted treatment (MAT) for OUD, but access is difficult for patients, especially in rural locations. To improve access, the Comprehensive Addiction and Recovery Act of 2016 extended the ability to get a Drug Enforcement Administration (DEA) waiver to prescribe buprenorphine to treat OUD to nurse practitioners (NPs) and physician assistants (PAs). This study summarizes the geographic distribution of waivered physicians, NPs, and PAs at the end of 2017 and compares it to the distribution of waivered physicians 5 years earlier.
Methods: Using the DEA list of providers with a waiver to prescribe buprenorphine to treat OUD and the Area Health Resources File, we assigned waivered providers to counties in 1 of 4 geographic categories. We calculated the number of counties in each category that did not have a waivered provider and county provider to population ratios and then compared our results to the waivered workforce in 2012.
Findings: The availability of a physician with a DEA waiver to provide office-based MAT has increased across all geographic categories since 2012. More than half of all rural counties (56.3%) still lack a provider, down from 67.1% in 2012. Almost one-third (29.8%) of rural Americans compared to 2.2% of urban Americans live in a county without a buprenorphine provider. NPs and PAs add otherwise lacking treatment availability in 56 counties (43 rural).
Conclusions: Overall, MAT access has improved, but rural communities still experience treatment disparities.
Keywords: buprenorphine; medication-assisted treatment; opioid treatment programs; opioid use disorder; rural health.
© 2018 National Rural Health Association.
Similar articles
-
Tracking the geographic distribution and growth of clinicians with a DEA waiver to prescribe buprenorphine to treat opioid use disorder.J Rural Health. 2022 Jan;38(1):87-92. doi: 10.1111/jrh.12569. Epub 2021 Mar 18. J Rural Health. 2022. PMID: 33733547
-
Prescribing Practices of Nurse Practitioners and Physician Assistants Waivered to Prescribe Buprenorphine and the Barriers They Experience Prescribing Buprenorphine.J Rural Health. 2020 Mar;36(2):187-195. doi: 10.1111/jrh.12404. Epub 2019 Oct 25. J Rural Health. 2020. PMID: 31650634
-
In Rural Areas, Buprenorphine Waiver Adoption Since 2017 Driven By Nurse Practitioners And Physician Assistants.Health Aff (Millwood). 2019 Dec;38(12):2048-2056. doi: 10.1377/hlthaff.2019.00859. Health Aff (Millwood). 2019. PMID: 31794302 Free PMC article.
-
Implications of Increased Access to Buprenorphine for Medical Providers in Rural Areas: A Review of the Literature and Future Directions.Cureus. 2021 Nov 24;13(11):e19870. doi: 10.7759/cureus.19870. eCollection 2021 Nov. Cureus. 2021. PMID: 34976492 Free PMC article. Review.
-
Buprenorphine X-waiver exemption - beyond the basics for the obstetrical provider.Am J Obstet Gynecol MFM. 2021 Nov;3(6):100451. doi: 10.1016/j.ajogmf.2021.100451. Epub 2021 Jul 25. Am J Obstet Gynecol MFM. 2021. PMID: 34320429 Review.
Cited by
-
Prevalence and predictors of medication for opioid use disorder among reproductive-aged women.Drug Alcohol Depend Rep. 2024 Apr 26;11:100239. doi: 10.1016/j.dadr.2024.100239. eCollection 2024 Jun. Drug Alcohol Depend Rep. 2024. PMID: 38711835 Free PMC article.
-
County-level factors associated with a mismatch between opioid overdose mortality and availability of opioid treatment facilities.PLoS One. 2024 Apr 5;19(4):e0301863. doi: 10.1371/journal.pone.0301863. eCollection 2024. PLoS One. 2024. PMID: 38578818 Free PMC article.
-
Trends in prenatal prescription opioid use among Medicaid beneficiaries in Wisconsin, 2010-2019.J Perinatol. 2024 Apr 1. doi: 10.1038/s41372-024-01954-y. Online ahead of print. J Perinatol. 2024. PMID: 38561393
-
Post-hospitalization Care Transition Strategies for Patients with Substance Use Disorders: A Narrative Review and Taxonomy.J Gen Intern Med. 2024 Apr;39(5):837-846. doi: 10.1007/s11606-024-08670-5. Epub 2024 Feb 27. J Gen Intern Med. 2024. PMID: 38413539 Review.
-
Addressing the Spectrum of Opioid Misuse Prevention, Treatment, and Recovery in Rural Washington State Communities: Provider Identified Barriers and Needs.Community Ment Health J. 2024 Apr;60(3):600-607. doi: 10.1007/s10597-023-01215-w. Epub 2024 Jan 10. Community Ment Health J. 2024. PMID: 38200378 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical